,,iv  #aai? ,,congress  #a/ ,session    
,h4 ,,res4 #ecb  ,,9 ,,! ,,h\se ,,(     
,,repres5tatives  ,june #bc1 #bjbe,mrs4 
,f\%ee submitt$ ! foll[+ resolution2 :i*
 0 ref]r$ to ! ,committee on ,en]gy &   
,comm]ce  ,,resolution  ,support+ !     
designation ( ,bra9 & ,sp9e ,meta/asis  
,aw>5ess ,mon?4  ,:]eas bra9 & sp9e     
meta/asis c occur ) almo/ any type (    
canc]2 ,:]eas improv$ canc] treatm5ts   
are lead+ to long] pati5t survival1 b   
bra9 & sp9e meta/asis rates are         
increas+2 ,:]eas specific canc]s        
commonly spread to ! bra9 & sp9e1 su* z 
melanoma1 lung1 brea/1 colon1 & pro/ate 
canc]s2 ,:]eas bra9 meta/ases are a     
lead+ cause ( morbidity & mortality 9   
pati5ts ) canc]2 ,:]eas bra9 meta/ases  
are five times m common ?an prim>y bra9 
tumors2 ,:]eas advanc$ treatm5t options 
are available to improve pati5t         
outcomes2 ,:]eas disp>ities 9 canc] c>e 
exi/1 & aw>5ess is crucial to address ^!
 disp>ities2 ,:]eas diff]5t treatm5ts   
are ne$$ = bra9 & sp9e meta/asis ?an =  

o!r canc]s2 ,:]eas !re are publicly     
available res\rces :]e pati5ts &        
families c f9d in=mation on bra9 & sp9e 
meta/asis2 & ,:]eas new & novel !rapies 
are (f]+ hope1 b m support & fund+ =    
cl9ical trials & specializ$ c5t]s are   
necess>y3 ,n[1 !re=e1 be x ,t ! ,h\se ( 
,repres5tatives-- 7#a7 supports !       
designation ( ,bra9 & ,sp9e ,meta/asis  
,aw>5ess ,mon?2  7#b7 recognizes &      
affirms ! commitm5t by ! ,h\se (        
,repres5tatives to increas+ aw>5ess (   
treatm5t options = p ) canc] t has      
spread to ! bra9 or sp9e2  7#c7         
recognizes & affirms ! d$ication ( !    
,h\se ( ,repres5tatives to increas+     
education = bra9 & sp9e meta/asis s     
individuals c bett] und]/& _! canc] or !
 canc] ( a lov$ "o2 &  7#d7 calls on !  
,secret>y ( ,heal? & ,human ,s]vices    
to-- 7,a7 increase education & aw>5ess  
ab\t treatm5t options available =       
pati5ts ) bra9 & sp9e meta/ases1 includ+
 advances & improvem5ts 9 m$ical        
!rapies1 su* z t>get$ !rapies or        

immuno!rapies2  7,b7 support res\rces to
 e/abli% & support c5t]s = bra9 & sp9e  
meta/asis2  7,c7 provide res\rces to    
increase access to d$icat$ cl9ical      
trials = pati5ts ) bra9 or sp9e         
meta/ases2 &  7,d7 inve/ 9 rese>*       
specifically into ! biology & treatm5t (
 bra9 & sp9e meta/asis1 p>ticul>ly      
across canc]s4